Compliance Notice: The PT/PTA supervision model is one of the most heavily audited operational structures in outpatient physical therapy. Medicare, Medicaid, and most commercial payors have specific — and sometimes conflicting — rules governing documentation, supervision level, and billing modifier requirements. This whitepaper is designed to be operationally actionable and compliant as written. Always confirm current payor-specific rules with your compliance counsel and billing team, as regulations are subject to update.
The single largest cost center in any outpatient physical therapy practice is clinical labor — specifically, Physical Therapist compensation. A full-time PT in most markets earns $70,000–$95,000 annually, plus benefits, while generating a fixed number of billable visits per day. The PT/PTA team model addresses this structural inefficiency by pairing one supervising PT with one or more Physical Therapist Assistants, allowing the PT to focus on evaluation, clinical decision-making, and high-complexity interventions while the PTA delivers a significant portion of established treatment units.
When structured correctly, this model simultaneously reduces the per-visit labor cost and expands total daily visit capacity — a rare operational lever that improves margin from both directions. A well-run PT/PTA team can achieve 35–50% lower direct labor cost per billable unit versus an all-PT clinic, without sacrificing care quality, outcomes, or billing integrity.
The challenge — and the reason many practices either under-utilize or mis-implement this model — is that federal and state regulations, combined with payor-specific billing rules, create a compliance landscape that demands precision. A PT/PTA arrangement that is wrong even one step in the documentation chain can result in denied claims, extrapolated audit liability, and even False Claims Act exposure. This whitepaper provides the operational, billing, and scheduling framework to do it right.
Before structuring any PT/PTA team arrangement, practice owners must understand two distinct regulatory layers. For billing — the CQ modifier, the 85% payment reduction, the 8-minute rule, and the KX modifier — federal Medicare rules remain the non-negotiable floor that Medicaid programs and commercial payors adopt or modify. For supervision, however, the 2025 CMS rule change has fundamentally shifted the hierarchy: Medicare now sets a permissive general supervision standard, and state Practice Acts have become the binding constraint in most markets. In a growing number of states, the PT does not need to be on-site — but what your state board requires is what actually governs your clinic’s daily operations.
Under Section 53107 of the Bipartisan Budget Act of 2018, implemented by CMS effective January 1, 2022, services furnished in whole or in part by a PTA must be reported with the CQ modifier and are reimbursed at 85% of the otherwise applicable Medicare Part B fee schedule amount. This payment differential applies across all outpatient physical therapy settings. There is no exception for rural or underserved areas.
Source: CMS Transmittal R4365CP, CR 11531; 42 CFR Part 410 and Part 414; MLN Matters MM11531
Effective January 1, 2025, CMS permanently changed the federal supervision standard for PTAs in outpatient private practice from direct supervision (PT physically in the office suite) to general supervision (PT available via telecommunications). This was finalized in the CY 2025 Medicare Physician Fee Schedule Final Rule (CMS-1809-F) and represents the most significant change to PT/PTA supervision policy in decades. The change aligns private practice with all other Medicare therapy settings and reflects 49 states that already permitted general supervision under state law. Critically: this rule change inverted the compliance hierarchy. Federal rules used to be the binding constraint on supervision. Now, state Practice Acts are. In states with general supervision, practices gain substantial scheduling flexibility. In states that still require direct supervision — including Arizona, Maryland, New Jersey, and Pennsylvania — state law controls and the federal change provides no relief. All supervision content in this whitepaper reflects the post-2025 standard; state law must be verified for every market.
Effective January 1, 2025, CMS finalized a major update to the Medicare Physician Fee Schedule (CMS-1809-F) that changed the federal supervision standard for PTAs in private practice from direct supervision to general supervision — aligning private practice with every other Medicare therapy setting. For outpatient physical therapy, the current standard is:
Note: SNF, home health, inpatient, and critical access hospital settings each carry their own distinct supervision frameworks under separate Medicare Conditions of Participation. Those settings are outside the scope of this whitepaper. Operators in those settings should seek separate compliance guidance specific to their setting.
What Changed in 2025: Prior to January 1, 2025, Medicare required direct supervision for PTAs in private practice — meaning the PT had to be physically present in the office suite at all times during PTA treatment. That requirement has been permanently eliminated at the federal level. Under current federal rules, a PT may be off-site during PTA treatment of Medicare patients, provided the PT is reachable by phone or other telecommunications. State Practice Act requirements remain in effect and may be more restrictive — always apply the stricter of the two standards.
Source: 42 CFR § 410.59; 42 CFR § 410.61; CMS Medicare Benefit Policy Manual, Chapter 15, §§ 220–230
A PTA may never independently establish or modify a Plan of Care. The supervising PT must:
Source: 42 CFR § 410.61(e); CMS Medicare Benefit Policy Manual, Chapter 15, § 220.3
These restrictions apply across Medicare, Medicaid, and most commercial payors, regardless of how the practice's internal policies are written:
The 2025 CMS rule change fundamentally inverted the supervision hierarchy. Before 2025, federal Medicare rules were the primary restrictor — requiring on-site PT presence that many state laws actually permitted practices to relax. Today, Medicare has moved to permissive general supervision, and state Practice Acts are now the ceiling that determines how much flexibility your clinic actually has. A practice in Texas operates very differently from one in Maryland or New Jersey, not because of Medicare, but because of what each state board permits. Understanding your state’s specific requirements — supervision level, PT:PTA ratio, first-visit rules, and scope of PTA practice — is now the first and most consequential compliance step for any PT/PTA team model.
Many states cap the number of PTAs a single PT may supervise simultaneously — commonly 2:1 or 3:1, though some states impose no statutory cap and instead defer to the PT's professional judgment. Exceeding a state-mandated ratio creates a Practice Act violation regardless of Medicare compliance. Some states interpret their ratio rules strictly and continuously rather than as a daily average — verify your state board's specific position, ideally in writing.
Following the 2025 CMS rule change, the federal standard for private practice is now general supervision. However, state definitions matter more than ever: some states still require direct supervision (PT physically present in the office suite), which overrides the more permissive federal standard. As of 2025, Arizona, Maryland, New Jersey, and Pennsylvania are among the states that continue to require direct supervision of PTAs in outpatient settings. Know your state's current definition — and monitor your state board for updates, as state rules may evolve in response to the CMS change.
Several states require the PT to personally evaluate and treat the patient on the first visit before delegating subsequent visits to a PTA. Some states extend this to the first visit under a new diagnosis or new episode of care, even for existing patients.
Certain advanced interventions — dry needling, manipulation, wound care, select electrical modalities — may be explicitly prohibited for PTAs in specific states even where PTAs otherwise practice broadly. Review your state Practice Act's PTA scope section for these carve-outs.
Before scheduling your first PT/PTA team day, obtain a written memo from your healthcare attorney confirming: (1) the permissible supervision ratio in your state, (2) the state’s supervision level requirement (general or direct — do not assume federal general supervision applies), (3) any first-visit or first-episode evaluation requirements, and (4) any modality or technique restrictions applicable to PTAs. Post-2025, this state-law memo is the operational blueprint for your entire PT/PTA model. Federal rules are no longer the limiting factor for most practices — your state board is. Update the memo annually; state Practice Acts are amended regularly and some states are actively revising their rules in response to the 2025 CMS change.
The Medicare 8-minute rule (one unit billed per 8–22 minutes; two units per 23–37 minutes, etc.) applies to PTA-delivered timed services exactly as it does to PT-delivered services. The CQ modifier reduces the payment rate; it does not change the unit calculation rules. All timed service minutes — whether delivered by the PT or PTA in the same visit — are pooled when applying the 8-minute rule to calculate total billable units.
Source: CMS Medicare Claims Processing Manual, Chapter 5, § 20.2
The KX modifier (used to attest medical necessity for services exceeding the annual Medicare therapy threshold) must still be applied appropriately on PTA-delivered services when applicable. The CQ and KX modifiers are used simultaneously when both conditions are met. For CY 2026, the KX modifier threshold for combined PT services is $2,480 (indexed annually by the Medicare Economic Index — confirm the current year’s figure at CMS.gov). The targeted medical review threshold remains at $3,000.
Source: CMS MLN Matters SE1613; annual CMS Physician Fee Schedule updates
The following comparative model illustrates the margin impact of deploying a PT/PTA team versus an equivalent all-PT staffing model at identical visit volume. Assumptions are conservative and based on typical outpatient PT economics. All figures are illustrative — actual results will vary by market, payor mix, and contract rates.
Clinic: 10 visits/day per clinician × 250 days/year. Avg. net revenue/visit (blended, all payors): $105. PTA Medicare visits billed at 85% rate (CQ modifier applied). Medicare = 40% of visit volume; Commercial = 45%; Other = 15%. PT annual fully-loaded cost: $95,000. PTA annual fully-loaded cost: $62,000.
| Metric | Solo PT Clinic (2 FT PTs) | PT/PTA Team (1 PT + 2 PTAs) | Difference |
|---|---|---|---|
| Annual Visit Capacity | 5,000 | 7,500 | +2,500 visits |
| Gross Revenue (at $105 avg.) | $525,000 | $787,500 | +$262,500 |
| Medicare GN Modifier Reduction (40% of visits × 15% reduction × $105) |
— | ($47,250) | — |
| Adjusted Net Revenue | $525,000 | $740,250 | +$215,250 |
| Direct Clinical Labor Cost | $190,000 (2 PTs × $95K) |
$219,000 (1 PT × $95K + 2 PTAs × $62K) |
+$29,000 |
| Clinical Labor Cost per Visit | $38.00 | $29.20 | −$8.80/visit |
| Gross Margin After Clinical Labor | $335,000 | $521,250 | +$186,250 |
| Incremental EBITDA (pre-overhead) | — | +$186,250 / year | |
At a 6× EBITDA multiple — conservative for a well-run outpatient PT practice — an incremental $186,250 in annual EBITDA from implementing the PT/PTA team model translates to approximately $1.1 million in additional enterprise value at close. The staffing restructuring itself, properly implemented 12–24 months before going to market, is one of the highest-return operational improvements available to any PT practice owner in a pre-sale EBITDA optimization program.
The single most important scheduling principle in a PT/PTA practice is payor-awareness. The correct clinician assignment for any visit is determined first by the patient's insurance, then by the clinical situation. The framework below provides operationally actionable rules for each major payor category. Confirm all rules with your billing team and contract terms, as payor-specific contracts may supersede general payor class rules.
Initial evaluation (97161–97163), re-evaluation (97164), Plan of Care establishment and certification. Under 2025 general supervision, PT being off-site does not alone trigger a PT-only visit — the PT must be reachable by telecommunications (or on-site if state law requires).
All timed CPT codes on any visit where PTA delivers >10% of total timed minutes. Bill at 85% rate. Document minute-by-minute clinician allocation in visit note.
Established patients with an active POC, routine therapeutic interventions, therapeutic exercises, and functional activities. Under the 2025 CMS rule, PT is not required to be physically on-premises — must be available via telecommunications. Apply state Practice Act if more restrictive.
PT must document a progress note and recertify the POC every 30 days (or at the certification interval applicable to the episode). PTA notes do not satisfy the recertification requirement.
PT only. No exceptions. Perform evaluation, establish POC, document anticipated PTA involvement in the plan.
PTA may treat. Confirm PT is available via telecommunications (or on-site if state law requires). PTA documents treatment note with minute allocation, including supervising PT name. Apply CQ modifier at billing.
PT must see the patient to perform a progress assessment and re-certify the POC. Schedule this as a PT-only visit in the EMR. PTA may not sign the certification.
PT should perform or co-attend discharge evaluation. Document discharge summary per CMS requirements.
Most MA plans follow Traditional Medicare rules as a baseline, including the CQ modifier and 85% payment reduction. However, some MA plans have negotiated different rates — verify your specific contract.
Many MA plans require prior authorization that may specify the treating clinician type. Review auth approvals — some explicitly authorize "PT services" which may or may not include PTA-delivered care under your contract.
Follow current Medicare supervision rules (CQ modifier, PT available via telecommunications per 2025 CMS rule, PT eval required) unless your MA contract explicitly states otherwise. Confirm whether the MA plan has adopted the 2025 general supervision standard or still contractually requires on-site supervision.
Pull each MA contract and identify whether PTA-delivered services are recognized, whether CQ modifier applies, and whether payment is reduced. Build a payor-specific modifier matrix in your billing system.
Medicaid PT/PTA rules vary dramatically by state. Some states follow Medicare rules; others prohibit PTA billing entirely for Medicaid populations; others have their own supervision ratio and modifier requirements.
Medicaid does not use the CQ modifier system. Instead, state Medicaid programs have their own billing rules — which may include different modifiers, separate PTA fee schedules, or outright exclusion of PTA services from coverage.
If your state Medicaid program covers PTA-delivered services, bill under the supervising PT's NPI per Medicaid provider enrollment. Confirm whether a separate rendering provider enrollment is required for the PTA.
Document the supervising PT's name and credentials in every PTA-delivered visit note. Some state Medicaid auditors require the PT co-signature on PTA notes — verify your state's requirement.
Confirm with your state Medicaid program or provider manual whether PTA-delivered services are a covered benefit. Do not assume Medicare rules apply.
Schedule PTA for established patients only. PT must perform initial evaluation. Apply state-required modifiers. Confirm PT co-signature requirement.
Schedule only PTs for all Medicaid patients. Document this in your payor scheduling matrix so front desk and scheduling staff do not inadvertently assign PTA to Medicaid patients.
Most commercial payors do not apply the 85% payment reduction for PTA services — they typically reimburse at the contracted rate regardless of whether PT or PTA delivers the service. This is the highest-margin segment of the PT/PTA model.
Commercial payors are increasingly adding PTA-specific language to contracts. Some now require a CQ-equivalent modifier or apply their own payment reduction. Pull and review your current contracts for any PTA-specific payment or authorization language.
Even without Medicare's mandatory rules, most commercial payors require (or strongly expect) the licensed PT to perform the initial evaluation. Confirm this in your provider manual or Credentialing Agreement.
Commercial payors typically defer to state Practice Act supervision requirements. Apply your state's supervision standard as the floor.
PT performs initial evaluation. Document clinical justification for PTA involvement in subsequent visits in the POC.
PTA appropriate for established, stable patients with well-documented POC. Commercial patients are the highest-value PTA assignment — full rate, no modifier reduction.
Maximize PTA assignment for commercial patients to preserve PT capacity for evaluations, complex cases, and new patient intake.
Workers' comp operates on state fee schedules that vary widely. Most do not have a Medicare-equivalent PTA modifier system — PTAs bill at the applicable service rate under the supervising PT's credentials.
Workers' comp adjusters sometimes resist or flag PTA-delivered care as "not authorized" when the original authorization specified PT services. Pre-notify the adjuster in writing when PTA will be involved in a workers' comp case, and document adjuster acknowledgment.
PT only — legally and practically. The PT's report carries weight in case management, IMEs, and legal proceedings.
Appropriate for routine therapeutic exercise and modalities on established patients with adjuster notification. Document PT oversight clearly.
Consider PT-only treatment for litigated or attorney-represented cases. Defense attorneys may challenge PTA involvement in depositions or IME reports.
TRICARE generally follows Medicare billing and supervision rules for PT/PTA services, including PT-only evaluations and CQ modifier requirements. With Medicare’s 2025 shift to general supervision, confirm whether TRICARE/DHA has adopted the same change — check current DHA policy guidance, as TRICARE has historically updated its supervision standards in step with Medicare but may have its own implementation timeline.
TRICARE Prime patients typically require referrals; TRICARE Select may allow direct access. Confirm whether your authorization covers both PT and PTA-delivered services.
Apply Medicare scheduling rules as the baseline. Confirm any TRICARE-specific modifier requirements with your billing team.
| Payor | PTA May Treat? | Rate Impact | Modifier Required? | PT Supervision Requirement | Best Scheduling Use |
|---|---|---|---|---|---|
| Medicare Part B | Yes — established patients | 85% of fee schedule | CQ — always when >10% | Available via telecom (2025 federal rule); on-site if state requires | Mid-episode, routine treatment |
| Medicare Advantage | Usually yes — verify contract | Often 85% — verify | Often CQ — verify | Per MA contract — confirm adoption of 2025 general supervision standard | Same as Medicare — confirm contract |
| Medicaid | State-dependent | Varies by state | State-specific or none | State Practice Act governs | Confirm eligibility before scheduling |
| Commercial | Generally yes | Full contracted rate (usually) | Typically none | State Practice Act governs | Priority PTA assignment — best margin |
| Workers' Comp | Yes — with adjuster notice | State fee schedule | State-specific | State Practice Act governs | Routine, non-litigated cases |
| TRICARE | Generally yes | Typically 85% | CQ per Medicare rules — verify with DHA | Confirm with DHA — likely aligned with 2025 Medicare general supervision | Mid-episode treatment only |
| Self-Pay | Yes — no payor restrictions | Practice rate | None | State Practice Act governs | Fully flexible PTA assignment |
Documentation is the linchpin of a compliant PT/PTA model. Audit defense begins and ends with the treatment note. A technically compliant billing submission backed by deficient documentation is still a false claim. The following elements are required in every PTA-delivered visit note for Medicare patients and are best practice for all payors.
The PTA's name and credentials must appear in the treatment note as the treating clinician. The supervising PT's name must also appear as the supervisor of record. The note must not be ambiguous about who provided the service — "seen by staff" is non-compliant.
For any visit where both PT and PTA provide timed services, the note must document the number of minutes each clinician spent delivering each timed CPT code. This is the only way to accurately apply the 10% threshold and the CQ modifier requirement. Example: "Therapeutic Exercise (97110): PT — 8 minutes, PTA — 12 minutes."
Each PTA note must reference the active PT-established Plan of Care by date and confirm the treatment provided is consistent with the current POC goals. Do not document PTA-initiated modifications to goals or interventions — flag these for PT review and POC update.
Under the 2025 CMS general supervision standard, the clinic's compliance documentation must demonstrate the supervising PT was available via telecommunications during PTA treatment (or physically on-site if required by state law). Maintain a supervision availability log documenting the PT's contact information and availability status for each PTA treatment period. In states still requiring on-site presence, a sign-in/sign-out log remains appropriate. EMR access timestamps remain useful corroborating evidence of supervisory engagement.
Some state Practice Acts and some payors require the supervising PT to co-sign PTA treatment notes. Even where not explicitly required, PT co-signature is a strong best practice — it evidences supervisory oversight and provides an audit defense layer. Confirm your state's requirement and build it into your EMR workflow.
Inform patients during the intake process that their treatment may be delivered in part by a Physical Therapist Assistant under PT supervision. While not universally required by law, this is an important transparency practice and reduces complaints that can trigger payor investigations. Document the disclosure in the intake notes.
Medicare medical necessity requires demonstrating skilled care and functional progress (or clinical justification for plateau). PTA notes that read as rote exercise logs without clinical reasoning are an audit red flag. Train PTAs to document: what was observed, what changed, what clinical decision was made, and how it relates to POC goals.
Maintain a documented communication record showing active clinical collaboration between the supervising PT and each PTA. Auditors look for evidence of genuine supervision — not just a name on a form. Weekly care conferences, documented via a brief EMR note or clinic log, substantiate the supervisory relationship.
Commission a written memo from a licensed healthcare attorney in your state confirming: permissible supervision ratios, supervision level requirement (general vs. direct), first-visit rules, and scope restrictions for PTAs. As of 2025, this memo — not Medicare guidance — is the single most important compliance document for your PT/PTA model. Federal Medicare supervision rules are now more permissive than most state requirements; your state board sets the real ceiling.
Work with your billing vendor to build a payor-level modifier matrix. Medicare and TRICARE: auto-apply CQ when PTA is selected as treating clinician. Commercial: no modifier by default. Flag Medicaid for manual review.
Configure your EMR to require clinician identification (PT vs. PTA) at the time of scheduling and note creation. Enable a timed-minutes-by-clinician field for all timed CPT codes. Build in a mandatory co-signature workflow where state law requires it.
Document the clinic's written supervision policy: applicable supervision standard (federal general supervision as of 2025, or more restrictive state standard if applicable), PT telecommunications availability requirements, PTA scope of permissible services, and documentation standards. This becomes the cornerstone of your compliance program documentation.
Pull every active payor contract and search for PTA, "physical therapist assistant," "CQ modifier," and "supervision" language. Note any payor-specific restrictions or payment reductions. Update your scheduling matrix accordingly.
Each group needs different training: PTAs need documentation standards, scope limits, and the 2025 supervision change; PTs need supervisory responsibility and telecommunications availability requirements; schedulers need the payor-specific matrix and state-law overlay; billers need the modifier system and audit exposure points.
Create a master schedule template that flags payor type for each patient and automatically limits PTA assignment to appropriate payor categories. Build in a PT availability confirmation step for any time block where PTAs are treating Medicare patients — confirming the PT is reachable by telecommunications (or on-site if state law requires).
Sample 20–30 PTA-delivered visits per quarter: verify CQ modifier application, PT supervision availability documentation, timed minute allocation, POC reference, and note quality. Correct errors prospectively and document the audit. This is your first line of audit defense.
CMS, OIG, and commercial payor Special Investigations Units (SIUs) have identified PT/PTA practices as a recurring audit target. The following patterns consistently appear in audit findings, settlement agreements, and OIG advisory opinions. Avoiding them is not only about compliance — it is about protecting the long-term value of the practice, which is a direct driver of enterprise value at sale.
The PT is nominally listed as supervisor but has no documented clinical interaction with the patient. Auditors look for a PT who supervises a disproportionate number of PTA patients with zero PT-treatment days in the record. Document PT interaction — co-treatment days, progress notes, POC reviews — as evidence of genuine supervision.
A Medicare patient who has zero PT-only treatment days and zero progress note dates in a 90-day episode is a red flag. Auditors expect to see PT involvement dates corresponding to at least the 30-day recertification intervals. Build PT-touch-point visits into the schedule.
Identical or near-identical PTA treatment notes across multiple visits or multiple patients indicate template abuse. Auditors use note-similarity software. Every treatment note must reflect the individualized clinical content of that specific visit — what happened, what was observed, what was changed.
Submitting Medicare claims without the CQ modifier when PTA delivered more than 10% of timed minutes is the single most common billing error in the PT/PTA model. At extrapolation, a single audit finding can result in repayment of 100× the sampled overpayment. This is a zero-tolerance compliance item.
Knowingly submitting Medicare claims without the required CQ modifier — or billing for PTA services where the supervising PT failed to meet the applicable supervision standard (telecommunications availability under federal rules, or on-site presence if required by state law) — can constitute a violation of the Federal False Claims Act (31 U.S.C. §§ 3729–3733). FCA penalties include treble damages plus an inflation-adjusted civil penalty per false claim — figures that currently exceed $14,000 on the low end and approach $29,000 on the high end per claim under current DOJ adjustments (updated annually under the Federal Civil Penalties Inflation Adjustment Act; confirm the current range via the DOJ Federal Register or HHS OIG website). In a practice submitting hundreds of claims per month, extrapolated exposure compounds rapidly. The OIG has specifically identified outpatient PT as an ongoing enforcement priority. Compliance is not optional — it is existential.
Supervision is the operational spine of the PT/PTA model — and as of 2025, your state board, not Medicare, is the entity that most constrains how that supervision must work. This section consolidates supervision requirements into a framework specific to outpatient physical therapy, organized around the post-2025 reality: Medicare has set a permissive federal floor, and the distance between that floor and your clinic’s operational ceiling is determined entirely by your state’s Practice Act. Understand the federal definitions, then immediately apply your state’s rules on top.
Medicare defines three levels of supervision that apply in different clinical settings. Understanding precisely which level governs your setting is the foundation of compliance:
Source: 42 CFR § 410.32(b); 42 CFR § 410.61; CMS Medicare Benefit Policy Manual, Chapter 15, §§ 220–230
| Outpatient Setting | Medicare Supervision Level | PT Physical Presence Required? | Key Requirement | Primary Authority |
|---|---|---|---|---|
| Private Practice / Outpatient Clinic | General Supervision | No — federal general supervision (2025) | PT must be available via telecommunications during PTA treatment. Physical on-site presence no longer required under federal rules as of Jan 1, 2025. State Practice Act may impose stricter standard (e.g., AZ, MD, NJ, PA) — verify your state. | 42 CFR § 410.60; CY 2025 MPFS Final Rule (CMS-1809-F) |
| Hospital Outpatient Dept. (HOPD) | General Supervision | Yes — on hospital campus | PT must be on the campus and immediately available; individual department or hospital policies may impose stricter internal requirements — confirm with facility compliance | 42 CFR § 410.61; CMS BPPM Ch. 15 |
This whitepaper addresses outpatient PT settings only. SNF, home health, inpatient, and critical access hospital settings operate under separate Medicare Conditions of Participation with materially different supervision frameworks — seek setting-specific compliance guidance for those environments.
Post-2025, state Practice Acts are no longer just a layer on top of federal rules — they are the primary determinant of what your clinic can actually do. The table below illustrates how supervision requirements vary by state. In states with general supervision and no ratio cap, the 2025 CMS change meaningfully expands operational flexibility. In states with direct supervision requirements or strict ratios, those state rules are binding regardless of what federal Medicare now permits. Always confirm current rules directly with your state physical therapy board before operationalizing the PT/PTA model.
| State | Supervision Level Required | Max PT:PTA Ratio | First-Visit Rule | Notes |
|---|---|---|---|---|
| Texas | General supervision (aligned with 2025 CMS rule) | No statutory cap — reasonable supervision standard | PT must evaluate before PTA treats | 22 TAC § 322.1; verify current state board position on telecommunications availability standard |
| Florida | General supervision (aligned with 2025 CMS rule) | No statutory cap | PT must establish POC first | F.S. § 486.161; PT responsible for PTA competence verification; confirm current board position |
| California | Supervision required — PT must be on-premises or readily available by telecommunications; verify current board position | 2 PTAs per PT (plus 1 aide) | PT must evaluate and establish POC; PTA may not perform evaluation or prepare discharge summary | BPC § 2622(b–c); BPC § 2630.3; California has an explicit statutory ratio cap — confirm current rules with PT Board of California |
| New York | General supervision | No statutory cap | PT must evaluate; PTA may not perform initial evaluation | Educ. Law Art. 136; confirm current NY OPMC guidance |
| Illinois | General supervision | No statutory cap | PT must establish POC before PTA treats | 225 ILCS 90/; verify current board position on telecommunications vs. on-premises standard |
| Georgia | General supervision | 3 PTAs per PT (verify current rule) | PT must evaluate first | O.C.G.A. § 43-33-1 et seq.; one of the few states with an explicit ratio; confirm current board interpretation |
| Tennessee | General supervision | 3 PTAs per PT (outpatient; verify current rule) | PT must perform initial evaluation | Tenn. Code Ann. § 63-13; ratio may differ by setting; verify current board position on off-site PT availability |
| Ohio | General supervision | No statutory cap | PT must evaluate; progress notes every 30 days required | O.R.C. § 4755; confirm current board position — Ohio may require on-site presence under state law notwithstanding federal general supervision change |
⚠ This table is illustrative only. State laws change. Verify all rules with your state physical therapy licensing board and a licensed healthcare attorney before implementation. Citations are provided as a starting reference, not as legal advice.
The American Physical Therapy Association (APTA) publishes a Model Practice Act (MPA) for physical therapy — a template that many state legislatures and licensing boards have used as the foundation for their own Practice Acts. The APTA MPA recommends general supervision as the standard for PT oversight of PTAs, and does not impose a specific numerical ratio. With Medicare now aligned to general supervision at the federal level, the APTA MPA and your state board’s adoption or deviation from it has become the most operationally significant compliance document for your clinic — more so than Medicare rules in most markets.
Practically speaking, this means:
Under the CY 2025 MPFS Final Rule, the PT is no longer required to be physically in the clinic while a PTA treats Medicare patients. The PT must simply be available via telecommunications — reachable by phone or other device — during the PTA’s treatment periods. This eliminates the prior "on-premises" constraint and gives practices substantially more scheduling flexibility: a PT can conduct off-site evaluations, attend continuing education, or manage administrative duties at another location while a PTA runs established treatment visits at the clinic.
The operative question is not what Medicare permits — it is what your state board requires. The federal general supervision standard sets a permissive minimum. Your state’s Practice Act determines the actual operational ceiling. If your state requires direct supervision — as Arizona, Maryland, New Jersey, and Pennsylvania currently do — the federal change is irrelevant to your daily operations. If your state permits general supervision and has no ratio cap, you can leverage the full flexibility the 2025 rule change provides. Know your state’s standard before building your scheduling model.
Even under general supervision, the PT’s availability must be documentable. Every clinic should have a written supervision availability protocol as part of its compliance program covering:
This protocol should be retained in the clinic’s compliance program documentation — the first document requested in a Medicare audit — and updated whenever applicable regulations change.
The distinction between supervision that existed and supervision that can be proven is the difference between passing an audit and repaying extrapolated overpayments. Auditors do not accept a PT’s oral assertion that supervision requirements were met. The following documentation system creates a defensible evidentiary record:
A log documenting the supervising PT’s location, contact number, and telecommunications availability during each PTA treatment period. Under the 2025 federal standard, this replaces the on-premises sign-in/sign-out requirement for most states. In direct-supervision states (AZ, MD, NJ, PA and others), continue maintaining an on-premises presence log. Retain records for a minimum of 7 years consistent with Medicare record retention requirements.
Most EMR systems log user access with timestamps. EMR login records during the PTA’s treatment window provide corroborating electronic evidence that the supervising PT was actively engaged and available — supporting the telecommunications availability requirement under general supervision. Confirm with your EMR vendor that access logs are retained and exportable for audit response.
A brief documented weekly meeting between the supervising PT and each PTA covering active patients, plan of care updates, and clinical concerns. Even a 5-minute EMR note stating which patients were discussed and any clinical changes made serves as evidence of genuine, ongoing supervision — not just a signature on a form.
Document every visit where the PT personally treats a PTA-managed patient — whether for the 30-day recertification, a progress check, or a co-treatment session. These records show auditors an active supervisory relationship. Build at least one PT-touch-point visit per 30 days into the schedule for every Medicare patient being primarily managed by a PTA.
Any time supervisory responsibility transfers from one PT to another, or the primary supervising PT’s availability status changes, document it immediately: date, time, names, contact information of the new supervising PT, and reason for the change. In direct-supervision states, document departures from and returns to the premises. This log is critical audit evidence that supervision was continuous and traceable for each claim period.
Each year, have every PT and PTA sign a written attestation confirming they have read and understand the clinic’s PT/PTA supervision policy, the applicable state Practice Act requirements, and the current Medicare supervision standard (general supervision as of January 1, 2025, or the applicable state standard if more restrictive). File these attestations in each employee’s personnel record. In an audit or OIG investigation, demonstrating a culture of documented compliance is a material mitigating factor.
One of the most underutilized revenue levers in the PT/PTA model is group therapy billing. When implemented correctly, group and concurrent treatment allows a single PTA to simultaneously treat multiple patients — generating multiple units of billable time in parallel — without violating Medicare or Practice Act requirements. Understanding the distinction between group therapy and concurrent treatment, and billing each correctly, is essential to capturing this revenue without audit exposure.
CPT 97150 covers therapeutic procedures performed with two or more patients simultaneously. It is an untimed code — billed once per patient per session regardless of duration. The clinician must be actively engaged with the group, not monitoring from a distance; the group must be performing activities directed toward each patient's individual goals; and each patient bills their own 97150 unit. PTAs may deliver group therapy under appropriate PT supervision. Apply the CQ modifier to PTA-delivered 97150 for Medicare patients as a conservative compliance position; confirm current MAC guidance with your billing team as explicit CMS guidance on untimed codes and the CQ modifier is limited.
Concurrent treatment occurs when one clinician treats two patients at the same time, each under their own individual CPT codes (e.g., 97110, 97530). Unlike group therapy, concurrent treatment bills individual timed codes for each patient. Medicare does not prohibit concurrent treatment but requires the clinician to provide direct attention to each patient as needed. Only bill the minutes of actual skilled intervention per patient — not the total elapsed session time applied equally to both patients.
Source: CPT Professional Edition, AMA; CMS Medicare Claims Processing Manual, Chapter 5; CMS BPPM Chapter 15, § 220
A PTA running a 45-minute group session with four Medicare patients each billed at 97150 generates four billable units simultaneously — at a fraction of the per-patient time cost of four individual visits. For established patients in the mid-to-late episode performing progressive strengthening, balance training, or supervised functional activities, group delivery is clinically appropriate and operationally efficient. Build a weekly group slot into the PTA's schedule for appropriate patient cohorts such as post-surgical strengthening, fall prevention, or chronic pain management. Document group composition, goals addressed, and individual patient responses in each patient's note.
The single most common group therapy audit finding is clinicians billing 97150 for what is functionally unsupervised gym time — patients performing their home exercise program in a clinic space while a staff member is nominally present. Medicare requires active, skilled clinician involvement throughout the session. If a patient can safely perform the activity independently without real-time skilled instruction or cueing, it does not meet the medical necessity standard for billable group therapy. Reserve group billing for sessions where the clinician is actively directing, instructing, and responding to each patient throughout.
The PT/PTA model does not simply replace PT visits with PTA visits — it fundamentally restructures the PT's clinical day. A PT operating solo sees patients sequentially from open to close. A PT operating as a team supervisor shifts their time toward high-value activities: evaluations, re-evaluations, complex clinical decision-making, and supervisory oversight, while the PTA carries the established treatment caseload. Done correctly, this produces more total billable visits per day at lower average labor cost, with the PT spending more time on the work only a PT can legally perform.
| Role | Daily Visit Target | Optimal Visit Mix | Avg. Units/Visit | Notes |
|---|---|---|---|---|
| Supervising PT (Team Model) | 8–10 visits/day | 3–4 evals + 4–6 direct treatment visits + supervisory oversight time | 4–5 units | Evaluations are the PT's highest-value billable activity; front-load eval slots in the morning when documentation is manageable and clinical thinking is sharpest |
| PTA (Team Model) | 10–14 visits/day | All established treatment visits; no evals; 1–2 group therapy slots where clinically appropriate | 3–4 units | PTA throughput is the volume driver of the model; efficient 45-minute slots with streamlined documentation are critical to hitting the upper end of this range |
| Solo PT (No PTA) | 10–12 visits/day | Mixed evals and treatment visits; no delegation possible | 4–5 units | Volume ceiling is set by a single clinician's capacity; expansion requires adding another PT, not a more efficient use of the existing clinician's time |
Targets based on typical outpatient PT operations assuming 45-minute treatment slots, adequate room availability, and standard EMR documentation time. Adjust for your market, payor mix, and scheduling efficiency.
The following template illustrates how a supervising PT's day should be structured in a PT/PTA team model. The PT is fully productive — their schedule is engineered around high-value activities only a PT can perform, while PTA-delivered treatment fills parallel patient slots throughout the day.
| Time Block | PT Activity | PTA Activity | Billing Generated |
|---|---|---|---|
| 7:30–8:00 AM | Chart prep, POC reviews, daily check-in with both PTAs on active patient concerns | Room setup, schedule review | Administrative (non-billable) |
| 8:00–10:30 AM | 3 Initial Evaluations (97161–63) — new patients, workers' comp intakes, complex post-surgical cases; highest-value billable block of the PT's day | 5–6 established treatment visits on active POCs; PT available via telecom (or on-site per state law) | 3 PT evals (4–5 units each) + PTA treatment visits (3–4 units; CQ modifier on Medicare) |
| 10:30–11:00 AM | Eval documentation, POC authorship, progress notes for Medicare 30-day recertifications due | Continued treatment visits; PT available via telecom (or on-site per state law) | PT documentation (non-billable); PTA visits continue generating revenue |
| 11:00 AM–1:00 PM | 2–3 PT direct treatment visits — complex or manual-therapy-heavy patients, Medicare 30-day touch-points, co-treatment with PTA on high-complexity cases | 4–5 treatment visits + 1 group therapy slot (97150) where appropriate; PT available via telecom (or on-site per state law) | PT direct visits (100% rate) + PTA visits (CQ on Medicare) + group billing |
| 1:00–1:30 PM | Lunch — Under 2025 federal rules, PT may be off-site if reachable by phone. PTA may continue treating all patients. In direct-supervision states, PT must remain on-site. | All established patients may be treated; apply state law if stricter | Full PTA schedule continues; comply with state law if stricter |
| 1:30–4:00 PM | 1–2 afternoon evals + remaining PT direct treatment visits + re-evaluations (97164) as needed | 5–6 afternoon treatment visits; PT available via telecom (or on-site per state law) | PT evals + PTA afternoon treatment block (CQ modifier on Medicare) |
| 4:00–5:00 PM | Documentation wrap-up; discharge planning; brief PT–PTA clinical conference; co-signature of PTA notes where required by state law | Final visits, note documentation, room breakdown | Final afternoon visits; end-of-day admin |
Not every patient is appropriate for PTA assignment at every point in their episode. The following framework guides caseload distribution to protect care quality, satisfy Medicare requirements, and optimize clinician time allocation across the day.
Initial evaluations (all payors); re-evaluations (97164); patients with complex, unstable, or rapidly changing presentations; any patient whose POC requires frequent modification; Medicare 30-day recertification visits; patients where state law restricts PTA involvement; workers' comp cases requiring legal documentation.
Established patients (2+ visits completed) with a well-documented, stable POC; patients performing progressive therapeutic exercise or functional activities within a defined protocol; patients in mid-to-late episode trending toward goals; routine post-surgical rehab at established protocol milestones; group therapy participants; commercial and workers' comp patients on stable POCs (full rate, no modifier reduction).
New diagnosis or new episode for an existing patient; patients returning after a gap (>30 days); patients reporting a significant change in condition; post-operative patients at protocol transition points; patients with comorbidities that add clinical complexity; any patient the PTA flags for PT reassessment. Default to the PT when in doubt.
Overlay the clinical decision with the payor scheduling matrix from Section 6. A patient who is clinically appropriate for PTA assignment but is approaching a Medicare 30-day recertification should be scheduled with the PT for that visit. Commercial patients who are clinically appropriate for PTA are the highest-priority PTA assignments — full contracted rate, no modifier reduction, best per-visit margin in the practice.
The PT/PTA model is only as strong as the PTA's clinical competency and documentation discipline. Before delegating an established caseload, the supervising PT must have a documented basis for confidence in that PTA's readiness. The following framework provides that structure.
Verify active state PTA licensure directly with the state board — do not rely solely on the PTA's representation. Confirm no disciplinary actions or license conditions. PTAs in outpatient private practice do not independently bill Medicare Part B — services are billed under the supervising PT's NPI. However, confirm with your MAC whether your specific billing arrangement requires any PTA PECOS enrollment; requirements can vary by setting and contractor. At minimum, maintain the PTA's NPI documentation and state license in the employee file. Repeat license verification annually at renewal.
Before assigning an independent caseload, require a structured orientation — minimum 2–4 weeks — during which the supervising PT directly observes the PTA treating patients, reviews treatment notes in real time, and provides documented feedback. The PT should personally sign off on clinical readiness before transitioning to standard general supervision. Document orientation outcomes in the PTA's personnel file.
Clinical skill and documentation skill are separate competencies. Before full delegation, review 10–15 treatment notes authored by the PTA. Assess: Are timed minutes documented per CPT code? Is clinical reasoning present beyond exercise logs? Is the POC referenced? Are functional progress markers included? Weak documentation is an audit liability regardless of clinical skill — address it during orientation before it becomes an embedded pattern.
Confirm the PTA carries individual professional liability (malpractice) insurance in addition to the practice's entity coverage. While the supervising PT and practice entity carry primary coverage, individual PTA liability insurance is standard in compliant PT/PTA arrangements. Request a certificate of insurance and retain it in the employee file.
Supervising PT responsibility does not end at hire. Conduct an annual documented competency review: observe at least two patient treatments, review a sample of recent notes, confirm CEU compliance for license renewal, and discuss any clinical concerns. File the review in the PTA's personnel record. This annual review becomes evidence of active ongoing supervision in a Medicare audit or OIG investigation.
The most common objection to the PT/PTA model — from patients, referring physicians, and institutional buyers in due diligence — is that it sacrifices care quality in favor of cost reduction. The answer to that objection is data. A practice that systematically measures functional outcomes across its PT-only and PT/PTA caseloads, and can demonstrate equivalent or superior results in the PTA-managed cohort, converts a perceived liability into a competitive advantage. For practices approaching a sale, documented outcomes data is increasingly a component of buyer due diligence and can be presented directly in the Confidential Information Memorandum.
The most widely adopted outcomes platform in outpatient PT. FOTO provides risk-adjusted functional status scores, benchmarks performance against national norms, and produces reports suitable for payor credentialing, physician marketing, and institutional buyer due diligence. Implementing FOTO 12–24 months before going to market allows Mihama to include outcomes data alongside financial performance in the CIM.
The Outpatient Physical Therapy Improvement in Movement Assessment Log (OPTIMAL) and NIH PROMIS provide patient-reported functional trajectory data across an episode of care. PROMIS is increasingly valued by commercial payors in value-based contract arrangements and is used in a growing number of network credentialing programs. Low cost to implement; high value for credentialing and due diligence purposes.
Track the percentage of patients who achieve their documented POC goals at discharge, segmented by treating clinician type (PT vs. PTA). A PTA-managed cohort with a discharge goal attainment rate equivalent to the PT-managed cohort is the clearest clinical evidence that care quality is maintained under the team model. Review quarterly and retain results in the practice's quality program documentation.
Track average visits per episode and dropout rate (patients who stop before meeting goals), segmented by clinician type. An elevated dropout rate in the PTA-managed cohort relative to PT-managed is an early signal of a care quality or patient experience issue that should be addressed before it affects referral volumes or draws payor scrutiny.
Implement a post-discharge satisfaction tool and segment results by treating clinician type. Patient satisfaction is reviewed by commercial payors in network credentialing, by referring physicians making referral decisions, and by institutional buyers as part of reputational due diligence. Consistent scores across PT and PTA caseloads validate the model clinically and operationally.
A practice with 12–24 months of documented outcome data showing equivalent or superior results in the PT/PTA model — presented alongside financial performance in the CIM — commands stronger buyer confidence and supports a fuller multiple at close. Buyers discount practices where the PT/PTA model is operationally deployed but clinically unmonitored. Documented quality data converts the model from a cost-cutting measure into a scalable, institutionally credible clinical program.
For practice owners approaching a sale, the PT/PTA team model is not just an operational efficiency play — it is a pre-sale EBITDA optimization strategy with direct impact on enterprise value. A compliance-first implementation, documented in clinic policies and reflected in clean billing records, gives institutional buyers the confidence to pay a full multiple on the expanded earnings. A model that is technically deployed but improperly documented becomes a liability that sophisticated buyers discount or exclude from normalized EBITDA entirely. Mihama works with sellers to ensure operational improvements are implemented, documented, and defensible before the practice goes to market.
347-878-2141
Confidential consultation — no retainer required
info@mihamainc.com
We respond within one business day
www.mihamainc.com
Resources, case studies & transaction experience